Online pharmacy major Tata 1mg has made a strategic investment in digital diagnostic platform 5C Network.
Other angel investors like Vikram Vuppala, Founder and CEO of NefroPlus. Om Manchanda, MD, Lal Pathlabs and Viren Prasad Shetty, COO, Narayana Health also participated in the round. Launched in 2016 by Kalyan Sivasailam and Syed Ahmed, 5C reported over 1.5 million scans in 2021 from clinical centers in 334 cities across India.
Kalyan Sivasailam, CEO and Co-Founder, 5C Network, said, “Through our proprietary AI-powered reporting platform, 5C has the ability to report complex radiology cases in less than 60 minutes and has helped over 3.5 million patients. Have helped deliver more diagnoses. Across 27 states. We are delighted to partner with the Tata 1mg team and some of India’s leading health care ambassadors who are vibrant with our vision. The opportunity for scale and impact is enormous and we need to take this on Couldn’t find better partners to work with than us.”
“What impressed us the most was the pan-India reach of 5C and our focus on systematic service delivery that has benefited millions of patients across India. 1mg Co-Founder and CEO Prashant Tandon said, “We are delighted to partner with them and support them in their vision to improve health care outcomes by using technology, which is in line with our own values and Raison-Detre Resonates very closely.
5C Network is a digital platform that enables storage, sharing and interpretation of radiology images across India. 5C helps hospitals and diagnostic centers maximize ROI on their radiology machines by making specialists available round the clock.
Published on
18 March 2022